Therapie und Prophylaxe bei MRSA-Infektionen auf Intensivstationen

Intensivmedizin und Notfallmedizin

Volumn 36, Issue 7, 1999, Pages 612-618

  Geldner, G ^a   Zwing, M ^a   Trautmann, M ^b   Georgieff, M ^a   Wiedeck, H ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Decontamination; MRSA; Synercid; VRSA

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; FLUCLOXACILLIN; METICILLIN; OXACILLIN; PSEUDOMONIC ACID; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; COST BENEFIT ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION CONTROL; INTENSIVE CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; REVIEW; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE;

EID: 0032738875     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050352     Document Type: Article

References (60)

1. Aumercier M, Bouhallab S, Capmau ML, Le Goffic F (1986) Irreversible binding of pristinamycin IIA (streptogramin A) to ribosomes explains its lasting damage' effect. J Antibiot 39: 1322-1328
2. Aumercier M, Bouhallab S, Capmau ML, et al: RP 59500 (1992) A proposed mechanism for its bactericidal activity. J Antimicrob Chemother 30 (Suppl A): 9-14
3. Brumfitt W, Hamilton-Miller JMT (1989) Methicillin-Resistant Staphylococcus aureus. N Engl J Med 320 (18): 1188-1196
4. Carson CF, Cookson BD, Farrelly HD, Riley TV (1995) Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother 35: 421-424
5. Chapnick E, Gradon JD, Kreiswirth B, Lutwick L, Schaffer BC, Chiano TD, Levi HM (1996) Comparative killing kinetics of methicillin-resistant Staphylococcus aureus by bacitracin or mupirocin. Infect Control Hosp Epidemiol 17: 178-180
6. Chatfield CA, O'Neill WA, Cooke RP, McGhee KJ, Issacke M, Rahman M, Noble WC (1994) Mupiroein-resistent Staphylococcus aureus in a specialist school population. J Hosp Infect 26: 273-278
7. Cookson B (1989) Failure of mupirocin-resistant Staphylococcus to inactivate mupirocin. Eur J Clin Microbiol Infect Dis 8: 1038-1040
8. Cookson B (1995) Aspects of the epidemiology of MRSA in Europe, J Chemother 41: 93-98
9. Cookson B (1997) Controversies: Is it time to stop searching for MRSA? Screening is still important. BMJ Mar 1; 314: 664-665
10. Cox RA, Conquest C. Mallaghan C, Marples RR (1995) A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 29: 87-106
11. Craven DE, Reed C, Kollisch N, et al (1981) A large outbreak of infections cause by a strain of Staphylococcus aureus to oxacillin and aminoglycosides. Am J Med 71: 53-58
12. Crossley K. Loesch D, Landesman B, Mead K, Chern M, Strate R (1979) An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies. J Infect Dis 139: 273-279
13. Dacre J, Emmerson AM, Jenner EA (1986) Gentamicin-ethicillin-resistant Staphylococcus aureus: epidemiology and containment of an outbreak. J Hosp Infect 7: 130-136
14. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus: report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. J Hosp Infect 1986; 7: 193-201
15. Hackman BI, Tomasz A (1984) Low affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol 158: 513-516
16. Haley RW, Hightower AW, Khabbaz RF, Thornsberry C, Martone WJ, Allen JR, Hughes JM (1982) The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Ann Intern Med 97: 297-308
17. Hartmann BJ, Tomasz A (1986) Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob Agents Chemother 29: 85-92
18. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I (1997) Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogenously resistant to vancomycin. Lancet 350: 1670-1673
19. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40: 135-136
20. Jansen B (1991) Prävention von Staphylokokken-Infektionen durch antiinfektiöse Polymeroberflächen. In: Deutsch E, Gadner H, Graninger W, Kleinberger G, Lenz K, Ritz R, Schuster HP, Zaunschirm HA (Hrsg) Infektionen auf Intensivstationen. Springer, Wien, New York
21. Jansen B (1992) Kunststoffe in der Medizin - Anwendung und Probleme. Die Medizinische Welt 43: 896-901
22. Jernigan JA, Titrus MG, Gröschel DHM, Getchell-White SI, Farr BM (Effectiveness of Contact Isolation during a Hospital Outbreak of Methicillin-resistant Staphylococcus aureus. Am J Epidemiol 143 (5): 496-504
23. Jevons MP (1960) "Celbenin"-resistant staphylococci. Brit Med J 1: 124-125
24. Hohnson Z, Fitzpatrick P, Hayes C, Sayers G, Pelly H, McDonnell B, Thornton L, Buttimer J (1997) National survey of MRSA: Ireland, 1995. J Hosp Inf 35: 175-184
25. Kayser FH (1986) Grundlagen der Methicillinresistenz von Staphylokokken. Fortschr Antimikrob antineoplast Chemother 5-8: 1269-1273
26. Kramer A, Wallhäuser KH (1993) Wirkungsspektrum und Anwendungseigenschaften häufig aus prophylaktischer Indikation angewandter Antiseptika. In: Kramer A, et al (Hrsg) Klinische Antiseptik. Springer-Verlag: Berlin, Heidelberg
27. Kresken M, Hafner D (1996) Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa. Chemotherapie Journal 4: 225-230
28. Layton MC, Patterson JE (1994) Mupirocin resistance among consecutive isolates of oxacillin-resistant Staphylococcus aureus at a university hospital. Antimicrob Agents Chemother 38: 1664-1667
29. Linnemann CC Jr, Mason M, Moore P, Korfhagen TR, Staneck JL (1982) Methicillin-resistant Staphylococcus aureus: experience in a general hospital over four years. Am J Epidemiol 115: 941-950
30. Locksley RM, Cohen ML, Quinn TC, et al (1982) Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med 97: 317-324
31. Melo Cristino JA, Pereira AT, Afonso F, Naidoo JN (1986) Methicillin-resistant Staphylococcus aureus: a 6-month survey in a Lisbon paediatric hospital. J Hyg 97: 265-272
32. Mulligan M, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffman CA, Yu VL (1993) Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 94: 313-328
33. Naguib MH, Naguib MT, Flournoy DJ (1993) Mupirocin resistance in rnethicillin-resistant Staphylococcus aureus from a veterans hospital. Chemotherapy 39: 400-404
34. Panknin HT, Heuck D, Witte W (1994) Methicillin-resistente Staphylococcus aureus (MRSA) im Krankenhaus - Maßnahmen zur Infektionsverhütung. Krh.-Hyg. +Inf.verh, 16 Heft 3
35. Panlilio AW, Culver DH, Gaynes RP et al (1992) Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 13: 582-586
36. Pavillard R, Harvey K, Douglas D. Hewstone A. andrew J, Collopy B, Asche V, Carson P, Davidson A, Gilbert G, Spicer J, Tosolini F (1982) Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals. Med J Aust 1: 451-454
37. Pearman JW, Christiansen KJ, Annear DL et al (1985) Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex. Med J Aust 142: 103-108
38. Peacock JE Jr, Marsik FJ, Wenzel RP (1980) Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 93: 526-532
39. Peters G (1998) Multiresistente gram-positive Kokken. Dt Ärzteblatt 95: A-1601-1603
40. Rosdahl VT, Knudsen AM (1991) The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control 12: 83-88
41. Saravolatz LD, Markowitz N, Arking L. Pohlod D, Fisher E (1982) Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann Intern Med 96: 11-16
42. Seipp HM, Hehl J (1997) Multiresistente Staphylococcus aureus: Schnelle Resistenzentwicklung gegenüber Mupirocin und Wirksamkeit alternativer Produkte. Hyg Med 22 (2): 61-72
43. Seipp HM, Stroh A (1997) Multiresistente Staphylococcus aureus: Dekontamination und Vermeidung von Rekontamination. Hyg Med 22 (6): 285-305
44. Shah PM (1998) Infektionen durch multiresistente Staphylokokken. Chemotherapie Journal 2: 60-62
45. Shanson DC, Kensit JG, Duke R (1976) Outbreak of hospital infection with a strain of Staphylococcus aureus resistant to gentamicin and methicillin. Lancet 2: 1347-1348
46. Sieradzki K, Roberts RB, Haber SW, Tomasz A (1999) The development of vancomycin resistance in a patient with methicillin-resistant staphylococcus aureus infection. N Engl J Med 340: 517-523
47. Smith TL, Pearson ML, Wilcox KR, et al (1999) Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 340: 493-501
48. Suessmuth R, Ackermann B, Lingens F (1979) Mutagnic Effect of 1,1′-Hexamethylene-bis-([5-P-Ch1orophenyl]-Bieuanide). Chem-Biol Interactions 28: 249-258
49. Teare EL, Barrett SP (1997) Is it time to stop searching for MRSA? Stop the ritual of tracing colonized patients. BMJ Mar 1; 314: 665-666
50. Thomson RL, Cabezudo I, Wenzel RP (1982) Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 97: 309-317
51. Torralba MD, Frey SE, Lagging LM (1995) Treatment of methicillin-resistant Staphylococcus aureus infection with quinupristin/dalfopristin. Clin Infect Dis 21: 460-461
52. Trautmann M, Ruhnke M, Kresken M, Brauers J, Springsklee M, Marre R (1997) Quinupristin/Dalfopristin (RP 59500, Synercid®). Mikrobiologisches und klinisches Profil der ersten parenteralen Substanzkombination aus der Gruppe der Streptogramine, Chemotherapie Journal 1: 31-42
53. Vogel F (1992) Antibiotikatherapie von Staphylokokken-Infektionen. Intensivmedizin im Dialog 1: 1-7
54. Voss A (1993) Staphylokokken-Infektionen - Prophylaxe steht an erster Stelle. Physis Special 66
55. Voss A, Machka K, Lenz W, Milatovic D (1992) Vorkommen, Häufigkeit und Resistenzverhalten von Methicillin-Oxacillin-resistenten Staphylococcus-aureus-Stämmen in Deutschland. Dtsch Med Wschr 117: 1907-1912
56. Voss A, Milatovic D, Wallrauch-Schwarz C. Rosdahl VT, Baveby I (1994) Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13: 50-55
57. Waldvogel FA (1999) New resistance in Staphylococcus aureus. N Engl J Med 340: 556-557
58. Witte W, Braulke C, Heuck D, Klare I (1993) Aktuelle Aspekte der Epidemiologie von Krankenhausinfektionen mit Staphylococcus aureus. Bundesge-sundheitsblatt 8
59. Witte W, Cuny C, Braulke C, Heuck D. Klare I (1994) Überregionale, klonale Ausbreitung von Methicillin-resistenten S. aureus (MRSA) in Deutschland. Bundesgesundheitsblatt 1
60. Witte W, Heuck D (1993) Clonal dissemination of QR-MRSA result in from inappropriate hospital hygiene and prophylaxis. Drugs 45 (Suppl 3): 203